Natural product pharmacology: the British Journal of Pharmacology perspective.
chemical proteomics
drug discovery
natural products
Journal
British journal of pharmacology
ISSN: 1476-5381
Titre abrégé: Br J Pharmacol
Pays: England
ID NLM: 7502536
Informations de publication
Date de publication:
11 Aug 2024
11 Aug 2024
Historique:
received:
14
06
2024
accepted:
15
07
2024
medline:
12
8
2024
pubmed:
12
8
2024
entrez:
11
8
2024
Statut:
aheadofprint
Résumé
Natural products (NPs) have long been used as a rich source of bioactive compounds for drug development. Recent technological advancements have revitalised natural products research as evidenced by increased publications in this field. In this editorial review, we highlight key points from the 2020 British Journal of Pharmacology (BJP) practical guide, which outlines standards for natural products research reports, and provide papers published in BJP between years 2020 to 2023 that demonstrate adherence to these guidelines. Looking ahead, we discuss the potential of chemical proteomics approaches to elucidate natural products mechanisms of action and identify therapeutic targets for future research. By fostering innovation, we aim to advance natural products research and contribute to the development of novel therapeutics that will have a significant impact on healthcare.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
Références
Alexander, S. P. H., Fabbro, D., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Davies, J. A., Amarosi, L., Anderson, C. M. H., Beart, P. M., Broer, S., Dawson, P. A., Gyimesi, G., Hagenbuch, B., Hammond, J. R., Hancox, J. C., … Verri, T. (2023). The Concise Guide to PHARMACOLOGY 2023/24: Transporters. British Journal of Pharmacology, 180(S2), S374–S469. https://doi.org/10.1111/bph.16182
Alexander, S. P. H., Fabbro, D., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Davies, J. A., Annett, S., Boison, D., Burns, K. E., Dessauer, C., Gertsch, J., Helsby, N. A., Izzo, A. A., Ostrom, R., Papapetropoulos, A., … Wong, S. S. (2023). The Concise Guide to PHARMACOLOGY 2023/24: Enzymes. British Journal of Pharmacology, 180(Suppl 2), S289–S373. https://doi.org/10.1111/bph.16181
Alexander, S. P. H., Fabbro, D., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Davies, J. A., Beuve, A., Brouckaert, P., Bryant, C., Burnett, J. C., Farndale, R. W., Friebe, A., Garthwaite, J., Hobbs, A. J., Jarvis, G. E., … Waldman, S. A. (2023). The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors. British Journal of Pharmacology, 180(Suppl 2), S241–S288. https://doi.org/10.1111/bph.16180
Alexander, S. P. H., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Buneman, O. P., Faccenda, E., Harding, S. D., Spedding, M., Cidlowski, J. A., Fabbro, D., Davenport, A. P., Striessnig, J., Davies, J. A., Ahlers‐Dannen, K. E., Alqinyah, M., Arumugam, T. V., Bodle, C., … Zolghadri, Y. (2023). The Concise Guide to PHARMACOLOGY 2023/24: Introduction and other protein targets. British Journal of Pharmacology, 178(S1), S1–S26. https://doi.org/10.1111/bph.16176
Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., & Supuran, C. T. (2021). Natural products in drug discovery: Advances and opportunities. Nature Reviews. Drug Discovery, 20(3), 200–216. https://doi.org/10.1038/s41573-020-00114-z
Chen, X., Wang, Y., Ma, N., Tian, J., Shao, Y., Zhu, B., Wong, Y. K., Liang, Z., Zou, C., & Wang, J. (2020). Target identification of natural medicine with chemical proteomics approach: Probe synthesis, target fishing and protein identification. Signal Transduction and Targeted Therapy, 5(1), 72. https://doi.org/10.1038/s41392-020-0186-y
Dong, R.‐F., Qin, C.‐J., Yin, Y., Han, L.‐L., Xiao, C.‐M., Wang, K.‐D., Wei, R.‐Y., Xia, Y.‐Z., & Kong, L.‐Y. (2023). Discovery of a potent inhibitor of chaperone‐mediated autophagy that targets the HSC70‐LAMP2A interaction in non‐small cell lung cancer cells. British Journal of Pharmacology, 1–23. https://doi.org/10.1111/bph.16165
Feng, Z., Chen, J., Chen, C., Feng, L., Wang, R., Zhu, J., Lou, R., Liu, J., Ye, Y., & Lin, L. (2023). Bioactivity‐based molecular networking‐guided identification of guttiferone J from Garcinia cambogia as an anti‐obesity candidate. British Journal of Pharmacology, 180(5), 589–608. https://doi.org/10.1111/bph.15979
He, Q. R., Tang, J. J., Liu, Y., Chen, Z. F., Liu, Y. X., Chen, H., Li, D., Yi, Z. F., & Gao, J. M. (2021). The natural product trienomycin A is a STAT3 pathway inhibitor that exhibits potent in vitro and in vivo efficacy against pancreatic cancer. British Journal of Pharmacology, 178(12), 2496–2515. https://doi.org/10.1111/bph.15435
Izzo, A. A., Teixeira, M., Alexander, S. P. H., Cirino, G., Docherty, J. R., George, C. H., Insel, P. A., Ji, Y., Kendall, D. A., Panettieri, R. A., Sobey, C. G., Stanford, S. C., Stefanska, B., Stephens, G., & Ahluwalia, A. (2020). A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology: Reproducibility of natural product research. British Journal of Pharmacology, 177(10), 2169–2178. https://doi.org/10.1111/bph.15054
Kao, T. I., Chen, P. J., Wang, Y. H., Tseng, H. H., Chang, S. H., Wu, T. S., Yang, S. H., Lee, Y. T., & Hwang, T. L. (2021). Bletinib ameliorates neutrophilic inflammation and lung injury by inhibiting Src family kinase phosphorylation and activity. British Journal of Pharmacology, 178(20), 4069–4084. https://doi.org/10.1111/bph.15597
Lee, H. S., & Jeong, G. S. (2021). Therapeutic effect of kaempferol on atopic dermatitis by attenuation of T cell activity via interaction with multidrug resistance‐associated protein 1. British Journal of Pharmacology, 178(8), 1772–1788. https://doi.org/10.1111/bph.15396
Miao, H., Cao, G., Wu, X. Q., Chen, Y. Y., Chen, D. Q., Chen, L., Vaziri, N. D., Feng, Y. L., Su, W., Gao, Y., Zhuang, S., Yu, X. Y., Zhang, L., Guo, Y., & Zhao, Y. Y. (2020). Identification of endogenous 1‐aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation. British Journal of Pharmacology, 177(15), 3415–3435. https://doi.org/10.1111/bph.15062
Rao, Q., Ma, G., Li, M., Wu, H., Zhang, Y., Zhang, C., Ma, Z., & Huang, L. (2023). Targeted delivery of triptolide by dendritic cell‐derived exosomes for colitis and rheumatoid arthritis therapy in murine models. British Journal of Pharmacology, 180(3), 330–346. https://doi.org/10.1111/bph.15958
Wang, K. D., Zhu, M. L., Qin, C. J., Dong, R. F., Xiao, C. M., Lin, Q., Wei, R. Y., He, X. Y., Zang, X., Kong, L. Y., & Xia, Y. Z. (2023). Sanguinarine induces apoptosis in osteosarcoma by attenuating the binding of STAT3 to the single‐stranded DNA‐binding protein 1 (SSBP1) promoter region. British Journal of Pharmacology, 180(24), 3175–3193. https://doi.org/10.1111/bph.16202
Wang, Y., Gao, J., Yu, Y., Zhou, L., Wang, M., Xue, W., Liu, B., Wu, X., Wu, X., Gao, H., Shen, Y., & Xu, Q. (2023). A plant‐derived glucocorticoid receptor modulator with potency to attenuate the side effects of glucocorticoid therapy. British Journal of Pharmacology, 180(2), 194–213. https://doi.org/10.1111/bph.15957
Xiang, J., Yang, G., Ma, C., Wei, L., Wu, H., Zhang, W., Tao, X., Jiang, L., Liang, Z., Kang, L., & Yang, S. (2021). Tectorigenin alleviates intrahepatic cholestasis by inhibiting hepatic inflammation and bile accumulation via activation of PPARgamma. British Journal of Pharmacology, 178(12), 2443–2460. https://doi.org/10.1111/bph.15429
Yang, S. C., Wang, Y. H., Ho, C. M., Tsai, Y. F., Sung, P. J., Lin, T. E., & Hwang, T. L. (2023). Targeting formyl peptide receptor 1 with anteiso‐C13‐surfactin for neutrophil‐dominant acute respiratory distress syndrome. British Journal of Pharmacology, 180(16), 2120–2139. https://doi.org/10.1111/bph.16073
Zhang, C., Wang, N., Tan, H. Y., Guo, W., Chen, F., Zhong, Z., Man, K., Tsao, S. W., Lao, L., & Feng, Y. (2020). Direct inhibition of the TLR4/MyD88 pathway by geniposide suppresses HIF‐1alpha‐independent VEGF expression and angiogenesis in hepatocellular carcinoma. British Journal of Pharmacology, 177(14), 3240–3257. https://doi.org/10.1111/bph.15046
Zhang, L., Ma, X., Shi, R., Zhang, L., Zhao, R., Duan, R., Qin, Y., Gao, S., Li, X., Duan, J., & Li, J. (2023). Allicin ameliorates imiquimod‐induced psoriasis‐like skin inflammation via disturbing the interaction of keratinocytes with IL‐17A. British Journal of Pharmacology, 180(5), 628–646. https://doi.org/10.1111/bph.15983
Zhang, X. S., Lu, Y., Li, W., Tao, T., Peng, L., Wang, W. H., Gao, S., Liu, C., Zhuang, Z., Xia, D. Y., Hang, C. H., & Li, W. (2021). Astaxanthin ameliorates oxidative stress and neuronal apoptosis via SIRT1/NRF2/Prx2/ASK1/p38 after traumatic brain injury in mice. British Journal of Pharmacology, 178(5), 1114–1132. https://doi.org/10.1111/bph.15346
Zhu, W., Wang, M., Jin, L., Yang, B., Bai, B., Mutsinze, R. N., Zuo, W., Chattipakorn, N., Huh, J. Y., Liang, G., & Wang, Y. (2023). Licochalcone A protects against LPS‐induced inflammation and acute lung injury by directly binding with myeloid differentiation factor 2 (MD2). British Journal of Pharmacology, 180(8), 1114–1131. https://doi.org/10.1111/bph.15999
Zhu, X., Ye, S., Yu, D., Zhang, Y., Li, J., Zhang, M., Leng, Y., Yang, T., Luo, J., Chen, X., Zhang, H., & Kong, L. (2021). Physalin B attenuates liver fibrosis via suppressing LAP2alpha‐HDAC1‐mediated deacetylation of the transcription factor GLI1 and hepatic stellate cell activation. British Journal of Pharmacology, 178(17), 3428–3447. https://doi.org/10.1111/bph.15490